Hutchison-China Meditech (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities
Hutchison-China Meditech, China-based AIM and NASDAQ dual listed pharmaceutical company, is seeking to raise up to USD 500 million via a Hong Kong...
892 Views
HK Connect Discovery Weekly: CRRC, Car Inc/UCar (2019-01-25)
In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
672 Views
HK Connect Discovery Weekly: China Tower, Tencent, New China Life (2019-01-11)
In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...
714 Views
China Medical Devices: "Two-Invoice" Is Coming
Sinopharm Group Co H (1099 HK) 's pending acquisition of a majority interest in China National Scientific Instruments and Materials Co. Ltd....
823 Views
Sinopharm (1099 HK): Top Distributor of Pharma Products in China
Cheap on a gross profit basis, slow asset growth, and high level of cash sales relative to its sector Sinopharm is the top distributor of pharma...
259 Views